Atrial Fibrillation
Age, arrhythmia recurrence predict tricuspid regurgitation improvement after AF ablation
Among older adults who underwent catheter ablation for persistent atrial fibrillation, younger age and absence of late recurrence were good predictors of improvement of tricuspid regurgitation, which was tied to better outcomes, data show.
Gut microbiome composition associated with prevalent, incident atrial fibrillation
Adults with prevalent and incident atrial fibrillation have a different gut microbiome composition compared with people without AF, researchers reported.
Death related to procedural complications of AF ablation rare
Death associated with atrial fibrillation ablation occurred at a rate of 0.06% among patients treated at several Mayo Clinic locations, according to a large retrospective analysis published in Circulation: Arrhythmia and Electrophysiology.
Nurse-led counseling after ablation improved patients’ AF knowledge, reduced recurrence
An advanced nurse practitioner-led intervention after atrial fibrillation ablation could improve patient knowledge, satisfaction, lifestyle modification and AF recurrence, researchers reported.
Causal role of reproductive factors on women’s CVD health identified
Results of a Mendelian randomization study support a causal role of several reproductive factors on women’s risks for cardiovascular disease, according to researchers.
Consider revisiting reasons for anticoagulant nonuse among patients with AF
Revisiting reasons for patient refusal or physician choice not to prescribe oral anticoagulation could improve use of anticoagulants in patients with atrial fibrillation at increased risk, researchers reported.
Catheter ablation improved cognitive outcomes in older adults with atrial fibrillation
BOSTON — Older adults with atrial fibrillation who underwent catheter ablation developed less cognitive impairment than those receiving only medical management, according to a presenter at the American Academy of Neurology annual meeting.
Pulsed field ablation technique safe as first-time treatment for atrial fibrillation
In a real-world population, pulsed field ablation using a novel catheter was safe for most patients with atrial fibrillation in routine practice, with 78% free from AF at 1 year, registry data show.
Empagliflozin may lower AF risk by improving certain parameters of left atrial function
The antiarrhythmic benefits of empagliflozin in patients with and without diabetes may be explained by the SGLT2 inhibitor’s ability to improve left atrial strain reservoir and contraction phase values, researchers reported.
Novel score identifies those likely to improve heart failure symptoms after AF ablation
The novel ANTWERP score demonstrated good predictive value in identifying patients whose heart failure symptoms would improve after ablation for atrial fibrillation, a speaker reported.